Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Tu

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Organic Letters|January 1, 2025
Ni-Catalyzed Reductive Fluoroalkylthiolation of Alkynes toward Fluoroalkylated VinylthioethersMeng-Dan Wang, Ya-Nan Li, Lin-Xi Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2016
Discovery and preclinical evaluation of potent, orally bioavailable, metabolically stable cyclopropylindolobenzazepine acylsulfonamides as thumb site 1 inhibitors of the hepatitis c virus NS5B RNA-dependent, RNA polymerasePiyasena Hewawasam, Yong Tu, Min Gao, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Synergistic Activity of Combined NS5A InhibitorsDonald R O'Boyle, Peter T Nower, Min Gao, et al.
BMC Genomics|June 20, 2024
Multi-omic analysis reveals the effects of interspecific hybridization on the synthesis of seed reserve polymers in a Triticum turgidum ssp. durum × Aegilops sharonensis amphidiploidQian Hu, Jing Liu, Xiaolei Chen, et al.
Cancer Communications (London, England)|January 20, 2021
Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcomeWu-Tong Ju, Ying Liu, Li-Zhen Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donorBrian L Venables, Ny Sin, Alan Xiangdong Wang, et al.
Bioorganic & Medicinal Chemistry|May 23, 2022
Scaffold modifications to the 4-(4,4-dimethylpiperidinyl) 2,6-dimethylpyridinyl class of HIV-1 allosteric integrase inhibitorsKyle Parcella, Manoj Patel, Yong Tu, et al.
Nature|November 5, 2015
Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5AJin-Hua Sun, Donald R O'Boyle, Robert A Fridell, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase InhibitorKyle Parcella, Tao Wang, Kyle Eastman, et al.
Oncotarget|July 1, 2015
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Organic Letters|January 1, 2025
Ni-Catalyzed Reductive Fluoroalkylthiolation of Alkynes toward Fluoroalkylated VinylthioethersMeng-Dan Wang, Ya-Nan Li, Lin-Xi Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2016
Discovery and preclinical evaluation of potent, orally bioavailable, metabolically stable cyclopropylindolobenzazepine acylsulfonamides as thumb site 1 inhibitors of the hepatitis c virus NS5B RNA-dependent, RNA polymerasePiyasena Hewawasam, Yong Tu, Min Gao, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Synergistic Activity of Combined NS5A InhibitorsDonald R O'Boyle, Peter T Nower, Min Gao, et al.
BMC Genomics|June 20, 2024
Multi-omic analysis reveals the effects of interspecific hybridization on the synthesis of seed reserve polymers in a Triticum turgidum ssp. durum × Aegilops sharonensis amphidiploidQian Hu, Jing Liu, Xiaolei Chen, et al.
Cancer Communications (London, England)|January 20, 2021
Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcomeWu-Tong Ju, Ying Liu, Li-Zhen Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donorBrian L Venables, Ny Sin, Alan Xiangdong Wang, et al.
Bioorganic & Medicinal Chemistry|May 23, 2022
Scaffold modifications to the 4-(4,4-dimethylpiperidinyl) 2,6-dimethylpyridinyl class of HIV-1 allosteric integrase inhibitorsKyle Parcella, Manoj Patel, Yong Tu, et al.
Nature|November 5, 2015
Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5AJin-Hua Sun, Donald R O'Boyle, Robert A Fridell, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase InhibitorKyle Parcella, Tao Wang, Kyle Eastman, et al.
Oncotarget|July 1, 2015
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.
Pageof 7